Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchIndependent Academic Research Groups
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

Pfizer

United States
1 Trial

Pfizer is a multinational pharmaceutical corporation that, through Pfizer Canada and the Canadian Pain Society, co-funded the KetHead multi-center Phase 3 RCT (NCT05306899) evaluating high-dose IV ketamine for chronic daily headaches at Toronto Western Hospital and Sinai Health System. The trial targets NMDA receptor-mediated central sensitization underlying refractory headache disorders.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Big Pharma
HQ
United States
Website
Visit

Collaborated Trials

1
RecruitingIII

Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches

Start Date
Compounds
Ketamine, Placebo